


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.68%
-16.84%
MDT
Medtronic
$87.38
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
MDT Price Performance
$99.49 (-12.17%)
$97.72 (-10.58%)
$95.77 (-8.76%)
$87.63 (-0.29%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Eps growth
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
MDT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MDT Street Sentiment is extremely bullish and have positive views on the near-term outlook
MDT has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 13, 2026
Upgrade
Buy
Needham
Feb 10, 2026
Upgrade
Buy
Needham
Feb 05, 2026
Price Target Raised
Neutral
UBS
Jan 07, 2026
Upgrade
Outperform
William Blair
Dec 19, 2025
Reiterate
Hold
Truist Securities
MASI
Masimo Corporation C
175.50
+0.02%
ITGR
Integer Holdings Cor
83.30
-2.54%
What is MDT current stock price?
What are MDT stock strengths?
What is MDT Risk Level?
What is MDT market cap and volume?
What is MDT current Stock IQ?
Should I buy MDT stock right now?
Is MDT a Strong Buy right now?
What does a 'Strong Buy' rating mean for MDT?
What does a 'Strong Sell' rating mean for MDT?
What factors influence MDT's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
MDT
Medtronic
Current Price
$87.38
Runners Also Watch
MASI
Masimo Corporation C
175.50
+0.02%
ITGR
Integer Holdings Cor
83.30
-2.54%

MDT Price Performance
$99.49 (-12.17%)
$97.72 (-10.58%)
$95.77 (-8.76%)
$87.63 (-0.29%)
MDT Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Eps growth
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Outperform the market
MDT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MDT Street Sentiment is extremely bullish and have positive views on the near-term outlook
MDT has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
MDT Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
MDT Latest Analysis
Medtronic plc (MDT) Presents at Leerink Global Healthcare Conference 2026 Transcript.
Wed Mar 11, 2026
Medtronic plc (MDT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript.
Tue Mar 10, 2026
Medtronics $550 Million Scientia Vascular Deal Aims To Boost Neurovascular Portfolio. Medtronic plc (NYSE:MDT) shares are down on Tuesday as the company announced plans to acquire Scientia Vascular a move aimed at enhancing its neurovascular portfolio.This decline comes as broader markets are experiencing a downturn with major indices like the S&.P 500 and Nasdaq both in the red.$550 Million DealThe acquisition is expected to strengthen Medtronic’.s position in the neurovascular space in
Tue Mar 10, 2026
Medtronic To Buy Scientia Vascular . (RTTNews) - Medtronic PLC (MDT 2M6.DE) an Irish healthcare technology company said on Tuesday that it has inked a deal to acquire Scientia Vascular. The acquisition is valued at $550 million with potential undisclosed earn-out and milestone payments post-acquisition.
Tue Mar 10, 2026
Medtronic to buy Scientia Vascular for $550M.
Tue Mar 10, 2026
Medtronic Unit MiniMed Shares Fall 8% After $560 Million IPO. Shares of MiniMed Group Inc. a diabetes management firm that will be separated from health-care giant Medtronic Plc slid 8% in its trading debut after the firm raised $560 million in an initial public offering.
Fri Mar 6, 2026
Medtronics diabetes unit MiniMed drops on trading debut.
Fri Mar 6, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.